Profile
CADL VRTX REGN SGEN ARGX ALNY
Company Name Candel Therapeutics, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $423.41M $118.67B $73.71B $43.15B $38.90B $32.36B
Employees 0.04K 6.10K 15.11K 3.26K 1.15K 2.23K
CEO Dr. Paul-Peter Tak FOCIS, M.D., Ph.D. Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Timothy Van Hauwermeiren EMBA, M.Sc. Dr. Yvonne L. Greenstreet M.B.A., MBChB
Ratings
CADL VRTX REGN SGEN ARGX ALNY
Quant Rating Score 2 3 4 3 1 1
Quant Rating Sell Neutral Buy Neutral Strong Sell Strong Sell
Trading
CADL VRTX REGN SGEN ARGX ALNY
Last Close $12.21 $480.33 $696.02 $228.74 $647.49 $251
High 52 $14 $516.74 $1201.76 $228.74 $671.75 $296.75
Low 52 $1.4 $392.81 $663.86 $228.74 $356.01 $143.31
Price vs. 52 Week High -12.79 % -7.05 % -42.08 % 0 % -3.61 % -15.42 %
Price vs. 52 Week Low 772.14 % 22.28 % 4.84 % 0 % 81.87 % 75.14 %
Total Return
CADL VRTX REGN SGEN ARGX ALNY
1 Month Return 84.86 % 12.26 % 1.2 % 0 % 0.02 % -5.28 %
3 Month Return 195.28 % 6.65 % -6.51 % 0 % 8.5 % 1.7 %
6 Month Return 132.13 % -1.19 % -41.28 % 0 % 23.21 % -10.09 %
9 Month Return -0.49 % 8.67 % -29.97 % 0 % 81.54 % 67.76 %
YTD Return 40.67 % 19.28 % -2.29 % 0 % 5.28 % 6.67 %
1 Year Return 593.75 % 14.47 % -26.95 % 0 % 61.89 % 62.21 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
CADL VRTX REGN SGEN ARGX ALNY
Dividend Yield Percentage (TTM) - - - - - -
Dividend Paid and Capex Coverage Ration (TTM) -477.18 % -1.65 % 5.37 % -2.27 % -2.22 % -0.24 %
Dividend Per Share (TTM) - - - - - -
Payout Ratio (TTM) - - - - - -
Growth
CADL VRTX REGN SGEN ARGX ALNY
Asset Growth -46.97 % 25.23 % 13.23 % -1.21 % 44.93 % 7.99 %
Gross Profit Growth -2681.9 % 9.64 % 6.49 % 22.93 % 190.7 % 74.75 %
Revenue Growth -100 % 10.51 % 7.76 % 24.65 % 198.56 % 76.23 %
Revenue 3 Year -100 % 60.36 % 55.67 % 91.56 % 2071.96 % 241.5 %
Revenue 5 Year -100 % 219.55 % 110.3 % 215.48 % 3041.46 % 1865.57 %
Revenue 10 Year -100 % 610.45 % 549.62 % 494.04 % 9009.53 % 1810.11 %
EBIT Growth -10.57 % 0 % -14.6 % 10.13 % 40.94 % 64.06 %
Net Income Growth -1223.76 % 8.96 % -8.87 % 9.51 % 58.42 % 61.08 %
Net Income 3 Yeari Growth Per Share -72.36 % 34.59 % 13.48 % -763.59 % 64.01 % 52.78 %
Net Income 5 Yeari Growth Per Share -376.9 % 70.33 % 74.02 % -276.93 % -143.65 % 53.44 %
Net Income 10 Yeari Growth Per Share -376.9 % 809.6 % 871.12 % -624.16 % -857 % -143.14 %
Operating Income Growth -10.57 % 0 % -14.6 % 10.13 % 40.94 % 64.06 %
Operating Cash Flow Growth (CFG) -8.99 % -14.35 % -8.39 % 9.07 % 51.28 % 119.24 %
Operating 3 Year CFG -280.29 % 9.63 % 76.95 % -147.99 % 21.71 % 115.59 %
Operating 5 Year CFG -566.34 % 174.78 % 125.17 % -195.86 % -329.63 % 114.91 %
Operating 10 Year CFG -566.34 % 6084.35 % 713.56 % -2622.09 % -1280.2 % 174.76 %
EPS Growth -1217.91 % 8.33 % -8.54 % 10.81 % 60.46 % 62.15 %
EPS Diluted Growth -1217.91 % 8.35 % -9.03 % 10.81 % 60.46 % 62.15 %
Book Value Per Share -73.39 % 25.58 % 15.03 % -9.83 % 38.53 % -35.86 %
Share Holder 3 Year Equity Growth Per Share 154.49 % 104.06 % 137.56 % 33.72 % 94.42 % -119.99 %
Share Holder 5 Year Equity Growth Per Share 259.73 % 291.14 % 219.1 % 220.81 % 318.81 % -113.65 %
Share Holder 10 Year Equity Growth Per Share 259.73 % 1030.79 % 1286.9 % 691.19 % 3654.06 % -140.22 %
Dividend Per Share Growth - - - - - -
Dividend 3 Year Growth Per Share - - - - - -
Dividend 5 Year Growth Per Share - - - - - -
Dividend 10 Year Growth Per Share - - - - - -
Debt Growth -0.17 % 44.1 % 0.06 % -23.28 % 60.95 % 103.19 %
Free Cash Flow Growth -6.07 % -16.47 % -17.11 % 3.67 % 51.98 % 106.84 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022 31 Dec 2023 31 Dec 2023
Profitability
CADL VRTX REGN SGEN ARGX ALNY
Gross Profit Margin TTM 54.28 % 86.09 % 84.47 % 72.37 % 86.82 % 85.62 %
Return on Assets TTM -242.59 % -2.38 % 11.69 % -11.76 % -2.13 % -6.56 %
Return on Equity TTM 3209.78 % -3.28 % 14.77 % -16.53 % -2.75 % 905.33 %
Return on Capital Employed TTM -568.86 % -1.3 % 10.89 % -16.87 % -8.98 % -5.79 %
Net Income Per EBT TTM 100 % -215.53 % 92.32 % 100.55 % 167.72 % 73.71 %
EBT Per Ebit TTM 146.84 % -100.69 % 118.85 % 94.01 % 15.76 % 213.34 %
EBIT Per Revenue TTM -2001.58 % -2.24 % 28.32 % -36.09 % -17.08 % -7.87 %
Cash Flow To Debt Ratio TTM -178.69 % -28.16 % 222.76 % -185.98 % -428.57 % -0.64 %
Receivables Turnover TTM - 6.84 2.29 1.98 3.45 5.55
Payables Turnover TTM 2.74 3.71 2.79 1.54 1.06 3.66
Inventory Turnover TTM - 1.27 0.71 0.65 0.91 4.12
Fixed Asset Turnover TTM 57.46 % 425.82 % 308.76 % 256.83 % 6116.64 % 323.99 %
Asset Turnover TTM 8.25 % 48.84 % 37.61 % 34.46 % 47.09 % 53.02 %
Operating Cash Flow Per Share TTM -0.89 -1.91 41.08 -1.12 -2.42 -0.06
Free Cash Flow Per Share TTM -0.9 -3.07 33.43 -1.62 -3.52 -0.33
Cash Per Share TTM 51.72 % 2375.11 % 16647.4 % 657.5 % 5163.05 % 2095.42 %
Operating Cash Flow Sales Ratio TTM -1612.11 % -4.48 % 31.13 % -16.85 % -6.44 % -0.37 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.21 % 160.43 % 81.38 % 144.14 % 145.12 % 512.38 %
Cash Flow Coverage Ratios TTM -178.69 % -28.16 % 222.76 % -185.98 % -428.57 % -0.64 %
Price To Free Cash Flows Ratio TTM -14.76 -150.15 20.49 -141.85 -184.15 -759.92
Price To Operating Cash Flows Ratio TTM -10.64 -241.56 16.69 -203.89 -264.28 -3867.6
Price Cash Flow Ratio TTM -10.64 -241.56 16.69 -203.89 -264.28 -3867.6
Income Statement (TTM)
CADL VRTX REGN SGEN ARGX ALNY
Revenue $0B $11.02B $14.2B $1.96B $1.23B $2.25B
Gross Profit $-0.02B $9.49B $12.23B $1.55B $1.11B $1.92B
Gross Profit Ratio 0% 86.11% 86.13% 79.1% 90.39% 85.62%
EBITDA $-0.04B $0.49B $5.32B $-0.62B $-0.22B $-0.18B
Net Income $-0.04B $-0.54B $4.41B $-0.61B $-0.3B $-0.28B
EPS Diluted -1.31 -2.08 38.34 -3.3 -5.16 -2.16
Balance Sheet (MRQ)
CADL VRTX REGN SGEN ARGX ALNY
Long Term Debt $0.01B $1.66B $2.7B $0.04B $0.02B $0B
Total Liabilities $0.03B $6.12B $8.41B $0.87B $0.44B $4.17B
Total Equity $0.01B $16.41B $29.35B $2.8B $4.1B $0.07B
Total Investments $0B $6.65B $6.52B $1.42B $1.18B $1.73B
Total Debt $0.02B $1.75B $2.7B $0.04B $0.02B $1.3B
Total Assets $0.04B $22.53B $37.76B $3.67B $4.54B $4.24B
Cash Flow Statement (TTM)
CADL VRTX REGN SGEN ARGX ALNY
Net Income $-0.04B $-0.54B $4.41B $-0.61B $-0.43B $-0.28B
Inventory $0B $-0.52B $-0.62B $-0.23B $-0.08B $0.01B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.03B $-0.49B $4.42B $-0.45B $-0.42B $-0.01B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.08B $-0.04B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.78
AAPG 21.3
ABCL AbCellera Biologics Inc. 3.04
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.765
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.395
ABPWW 0.041
ABSI Absci Corporation 4.94
ABUS Arbutus Biopharma Corporation 3.415
ABVC ABVC BioPharma, Inc. 0.68
ABVX Abivax SA American Depositary Shares 7.98
ACAD ACADIA Pharmaceuticals Inc. 19.955
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.975
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.3888
ACHV Achieve Life Sciences, Inc. 3.17
ACIU AC Immune SA 2.64
ACLX Arcellx, Inc. 63.5
ETFs With Exposure to CADL
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00708 217.73
VTI Vanguard Total Stock Market Index Fund 0 296
IBB iShares Biotechnology ETF 0 139.1
IWO iShares Russell 2000 Growth ETF 0.0129 283.11
BIB ProShares Ultra Nasdaq Biotechnology 0 56.84
VXF Vanguard Extended Market Index Fund 0 190.465
HDG ProShares Hedge Replication ETF 0.000936397 50.02
UWM ProShares Ultra Russell2000 0.00273073 40.135
VTHR Vanguard Russell 3000 Index Fund 0 265.35
IWC iShares Micro-Cap ETF 0.04616 126.08
URTY ProShares UltraPro Russell2000 0.0015157 45.71
VFMO Vanguard U.S. Momentum Factor ETF 0.01 166.85
VTWG Vanguard Russell 2000 Growth Index Fund 0.01 206.415
VTWO Vanguard Russell 2000 Index Fund 0.01 88.04
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 103.13
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 103.11
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 49.89
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 49.88
VBINX Vanguard Balanced Index Fund Investor Shares 0 49.88
IBBQ Invesco Nasdaq Biotechnology ETF 0.01 22.91
VTSAX Vanguard Total Stock Market Index Fund 0 146.76
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.01 6.705
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 149.13
VITSX Vanguard Total Stock Market Index Fund 0 146.79
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 149.14
VEMPX Vanguard Extended Market Index InstlPlus 0 368.03
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 275.35
RSSL Global X Funds 0.01 87.11
RFLR Innovator ETFs Trust 0.03 25.46
Unlock